DEH Share Price | Vicarious Surgical, Inc. Stock Analysis & Recommendation

Q: Is Vicarious Surgical, Inc. technically bullish or bearish?

As of 3 September 2025, the technical trend for Vicarious Surgical, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with weak strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a bearish signal from the OBV on both weekly and monthly periods. The stock has underperformed significantly compared to the S&P 500 across multiple periods, with a year-to-date return of -55.47% versus the S&P 500's 12.22%.

Q: What does Vicarious Surgical, Inc. do?

Overview:Vicarious Surgical, Inc. is a company in the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap entity.Financial Snapshot:Most recent Net Profit: -15 Million (Quarterly Results - Mar 2025)Market cap: USD 45.44 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making)Industry P/E: NADividend Yield: 0.00%Debt Equity: -1.06Return on Equity: -186.15%Price to Book: 1.33Contact Details:Address: 10/F, Champion Tower, 3 Garden Road, CENTRAL None: 00000Tel: ['852 39735500']

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

33.35 k

Shareholding (Mar 2026)

FII

3.12%

Held by 22 FIIs

DII

80.60%

Held by 6 DIIs

Promoter

16.27%

Is Vicarious Surgical, Inc. technically bullish or bearish?

20-Sep-2025

As of September 3, 2025, Vicarious Surgical, Inc. is in a bearish trend with weak strength, indicated by bearish MACD and moving averages, and has underperformed the S&P 500 with a year-to-date return of -55.47%.

View full answer

How big is Vicarious Surgical, Inc.?

22-Jun-2025

As of Jun 18, Vicarious Surgical, Inc. has a market capitalization of 45.44 million and reported net sales of 0.00 million with a net profit of -61.62 million over the last four quarters. The balance sheet shows shareholder's funds of 46.70 million and total assets of 67.72 million.

View full answer

What does Vicarious Surgical, Inc. do?

22-Jun-2025

Vicarious Surgical, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $15 million and a market cap of $45.44 million. It has no dividend yield and negative key financial metrics, including a debt equity ratio of -1.06 and a return on equity of -186.15%.

View full answer

Who are in the management team of Vicarious Surgical, Inc.?

22-Jun-2025

As of March 2022, the management team of Vicarious Surgical, Inc. includes President and Director Donald Tang, CEO and Director David Chu, and directors Michael Kives, Fred Langhammer, and Terry Lundgren.

View full answer

Compare Vicarious Surgical, Inc. with Similar Stocks

DarioHealth Corp.Accelerate Diagnostics, Inc.Electromed, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 5 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.80

Return on Equity

-527.49%

Price to Book

0.51

Revenue and Profits:

Net Sales:

(Quarterly Results - Mar 2026)

Net Profit:

-7 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-75.18%

6 Months

-88.84%

1 Year

-87.04%

2 Years

-92.55%

3 Years

-66.82%

4 Years

-99.43%

5 Years

-92.99%

Vicarious Surgical, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-28.24%

EBIT to Interest (avg)

-68.18

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.06

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

38.84%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.51

EV to EBIT

0.05

EV to EBITDA

0.06

EV to Capital Employed

-1.39

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-527.49%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 12 Schemes (5.63%)

Foreign Institutions

Held by 22 Foreign Institutions (3.12%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 52.60% vs 9.41% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.30",
          "val2": "-15.40",
          "chgp": "52.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.30",
          "val2": "-15.40",
          "chgp": "52.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 20.57% vs 11.11% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-49.50",
          "val2": "-64.40",
          "chgp": "23.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-50.20",
          "val2": "-63.20",
          "chgp": "20.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-7.30

-15.40

52.60%

Interest

0.00

Exceptional Items

0.00

-0.10

100.00%

Consolidate Net Profit

-7.30

-15.40

52.60%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 52.60% vs 9.41% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-49.50

-64.40

23.14%

Interest

0.00

Exceptional Items

1.70

0.00

Consolidate Net Profit

-50.20

-63.20

20.57%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 20.57% vs 11.11% in Dec 2024

All Annual Results

Company CV

About Vicarious Surgical, Inc.

Vicarious Surgical, Inc.

Pharmaceuticals & Biotechnology

D8 Holdings Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Company Coordinates

Company Details

10/F, Champion Tower, 3 Garden Road , CENTRAL None : 00000

Tel: 852 39735500

Registrar Details